We are pleased to announce that MuCover® Oral Wound Dressing, independently developed by MoleculeX, has recently received official notification from the U.S. Food and Drug Administration (U.S. FDA) and obtained U.S. FDA 510(k) clearance as a medical device. This milestone provides MuCover® Oral Wound Dressing with an important regulatory foundation for entering the U.S. medical device market. U.S. FDA 510(k) clearance is a key requirement for medical devices seeking market

🌏 Moving Forward Toward Global Markets: MoleculeX's Recent Progress Recently, MoleculeX has continued to make progress. 🚀 On the product side, we are advancing our mucosal adhesion technology platform through two core product directions: an oral wound dressing for clinical care settings and an intra oral patch for daily-use oral care scenarios. We are also continuing to develop additional products based on this platform. 🚀 From a regulatory perspective, our oral wound dr